000243403 001__ 243403
000243403 005__ 20230212174148.0
000243403 0247_ $$2CORDIS$$aG:(EU-Grant)898858$$d898858
000243403 0247_ $$2CORDIS$$aG:(EU-Call)H2020-MSCA-IF-2019$$dH2020-MSCA-IF-2019
000243403 0247_ $$2originalID$$acorda__h2020::898858
000243403 035__ $$aG:(EU-Grant)898858
000243403 150__ $$aMetabolites as immunomodulatory additives for biomaterials$$y2020-08-01 - 2022-07-31
000243403 372__ $$aH2020-MSCA-IF-2019$$s2020-08-01$$t2022-07-31
000243403 450__ $$aMet4Bone$$wd$$y2020-08-01 - 2022-07-31
000243403 5101_ $$0I:(DE-588b)5098525-5$$2CORDIS$$aEuropean Union
000243403 680__ $$aThe biomaterials are crucial for the surgical remediation of bone defects caused by various diseases e.g. osteoporosis and traumatic fractures. However, there are several risks associated with this treatment; first, the surgical procedure itself carries a potential risk of inflammation and bone infection, second, the bone replacement can fail requiring revision surgery. In fact, the host immune response to implanted materials and devices is the main factor that will determine a long-term functional outcome of the biomaterial mediated treatment. Therefore, the bone biomaterial ability to modulate the local immune environment for favorable treatment outcomes has to be considered. The usage of bioactive metabolites has emerged as one of the most novel and potent approach for immune response modulation. The incorporation of metabolites with immune regulatory properties seems an especially attractive option for biomaterials as it would ensure site-specific delivery system and allow modulation of the microenvironment. The goal of this project is to develop novel biomaterials with incorporated metabolites as a potentially effective and safe strategy to modulate local immune response towards favorable outcomes of surgical bone remediation. To achieve it, the recent concept of metabolomics with the state of the art biomaterial design and research will be combined in this project. This proposal includes the transfer of knowledge to the host institution and the training of the researcher in new techniques and skills. The multidisciplinary nature of the project is strong, combining materials science, biochemistry, and molecular biology. Results have the potential to pave the way for novel biomaterials significantly improving clinical outcomes for patients suffering from bone injuries.
000243403 909CO $$ooai:juser.fz-juelich.de:899843$$pauthority$$pauthority:GRANT
000243403 909CO $$ooai:juser.fz-juelich.de:899843
000243403 980__ $$aG
000243403 980__ $$aCORDIS
000243403 980__ $$aAUTHORITY